These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 8997156)

  • 1. Adult-onset focal dystonias: presentation and treatment options.
    Esper GJ; Charles PD; Davis TL; Robertson D
    Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystonia, botulinum neurotoxin, and the aviator.
    Feinberg MJ
    Aviat Space Environ Med; 1999 Dec; 70(12):1235-7. PubMed ID: 10596783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin in the treatment of dystonias--a hospital based study.
    Gupta M; Singh G; Khwaja G
    J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-onset dystonia.
    Evatt ML; Freeman A; Factor S
    Handb Clin Neurol; 2011; 100():481-511. PubMed ID: 21496604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of focal dystonia with botulinic toxin].
    Gracia F; Castillo LC
    Rev Med Panama; 1996 Sep; 21(3):121-31. PubMed ID: 9280925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treating writer's cramp: 14 years' experience with botulinum toxin].
    Somma-Mauvais H; Soulayrol S; Duvocelle A; Azulay JP; Gastaut JL
    Rev Neurol (Paris); 2010; 166(6-7):630-8. PubMed ID: 20189211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal dystonia, with special reference to writer's cramp.
    Gordon NS
    Int J Clin Pract; 2005 Sep; 59(9):1088-90. PubMed ID: 16115186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Writer's cramp--a focal dystonia: etiology, diagnosis, and treatment.
    Rhoad RC; Stern PJ
    J Hand Surg Am; 1993 May; 18(3):541-4. PubMed ID: 8515033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of dystonia in Japan].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    Rinsho Shinkeigaku; 2005 Sep; 45(9):634-42. PubMed ID: 16248394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurosurgical management of dystonias].
    Taira T
    Rinsho Shinkeigaku; 2006 Nov; 46(11):970-1. PubMed ID: 17432236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is new in the era of focal dystonia treatment? Botulinum injections and more.
    Cetinkaya A; Brannan PA
    Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
    Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
    Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus statement for the management of focal dystonias.
    Williams A
    Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):655-9. PubMed ID: 8124547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin in the treatment of writer's cramp.
    Behari M
    J Assoc Physicians India; 1999 Jul; 47(7):694-8. PubMed ID: 10778589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal dystonia and repetitive motion disorders.
    Chen R; Hallett M
    Clin Orthop Relat Res; 1998 Jun; (351):102-6. PubMed ID: 9646753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.